Extending the lives of patients with brain cancer
25 Oct 2023 – Chimeric Therapeutics Limited (ASX:CHM) CEO and Managing Director Jennifer Chow discusses efficacy results for the company’s glioblastoma therapy.
Extending the lives of patients with brain cancer Read More »









